CMMB
Chemomab TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
CMMB vs peer average
92/100
CMMB vs. peer average (A vs. D)
Grade spread
B 2 · C 3 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
BOLT is the first available peer comparator.
Bolt Biotherapeutics is a micro-cap clinical biotech peer by size, but not a PSC read-through; useful mainly as a financing-risk and volatility benchmark.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CMMB
Chemomab Therapeutics
BOLT
Bolt Biotherapeutics
Grade
A
D
Momentum
84
41
Value
41
41
Sentiment
63
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs BOLT
CMMB / BOLT
Grade Position
Above peers
CMMB vs. peer average (A vs. D)
92/100
Momentum
84
CMMBValue
41
CMMBSentiment
63
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CMMB
BOLT is the first peer returned for this comparison set.